HTLV-1-associated infective dermatitis: Updates on the pathogenesis

Experimental Dermatology

Volumn 21, Issue 11, 2012, Pages 815-821

  McGill, Neilia Kay ^a   Vyas, Jui ^a   Shimauchi, Takatoshi ^b   Tokura, Yoshiki ^b   Piguet, Vincent ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Childhood dermatitis; Filaggrin; HTLV 1 associated infective dermatitis; Human T Cell lymphotropic virus type 1; Infective dermatitis; Staphylococcus aureus.

Indexed keywords

CHEMOKINE; CYTOKINE; FILAGGRIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; PROTEINASE; TRANSCRIPTION FACTOR FOXP3;

DERMATITIS; GENETICS; HEREDITY; HISTOPATHOLOGY; HOST; HTLV 1 ASSOCIATED INFECTIVE DERMATITIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; LANGERHANS CELL; MALNUTRITION; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SOCIAL STATUS; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; THEORY;

DERMATITIS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNE TOLERANCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 84871853144     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12007     Document Type: Review

References (171)

1. LaGrenade L, Hanchard B, Fletcher V et al. Lancet 1990: 336: 1345-1347.
2. Sweet R D. Br J Dermatol 1966: 78: 93-100.
3. Walshe M M. Br J Dermatol 1967: 79: 229-236.
4. LaGrenade L, Manns A, Fletcher V et al. Arch Dermatol 1998: 134: 439-444.
5. Poiez B J, Ruscetti F W, Gazdar A F et al. Proc Natl Acad Sci USA 1980: 77: 7415-7419.
6. Yoshida M, Miyoshi I, Hinuma Y. Proc Natl Acad Sci USA 1982: 79: 2031-2035.
7. Van Dooren S, Salemi M, Vandamme A M. Mol Biol Evol 2001: 18: 661-671.
8. Miura T, Fukunaga T, Igarashi T et al. Proc Natl Acad Sci USA 1994: 91: 1124-1127.
9. Gessain A, Gallo R C, Franchini G. J Virol 1992: 66: 2288-2295.
10. Couroucé A-M, Pillonel J, Lemaire J-M et al. AIDS 1993: 7: 841-847.
11. Courtois F, Barin F, Larsen M et al. Lancet 1990: 335: 1103.
12. Nightingale S, Orton D, Ratcliffe D et al. Epidemiol Infect 1993: 110: 379-387.
13. Donati M, Seyedzadeh H, Leung T et al. BMJ 2000: 320: 92-93.
14. Brennan M, Runganga J, Barbara J A et al. BMJ 1993: 307: 1235-1239.
15. Banatvala J E, Chrystie I L, Palmer S J et al. Lancet 1990: 335: 859-860.
16. Tosswill J H, Ades A E, Peckham C et al. BMJ 1990: 301: 95-96.
17. Glynn S A, Kleinman S H, Schreiber G B et al. JAMA 2000: 284: 229-235.
18. Dourado I, Alcantara L C, Barreto M L et al. J Acquir Immune Defic Syndr 2003: 34: 527-531
19. Bittencourt A L, Dourado I, Filho P B et al. J Acquir Immune Defic Syndr 2001: 26: 490-494.
20. Galvão-Castro B, Loures L, Rodriques L et al. Transfusion 1997: 37: 242-243.
21. Sanchez-Palacious C, Gotuzzo E, Vandamme A M et al. Int J Infect Dis 2003: 7: 132-137.
22. Safai B, Juang J L, Boeri E et al. AIDS Res Hum Retroviruses 1996: 12: 1185-1190.
23. Armah H B, Narter-Olaga E G, Adjei A A et al. J Med Microbiol 2006: 55: 765-770.
24. Mboudjeka I, Zekeng L, Yamashita M et al. Jpn J Cancer Res 1997: 88: 619-624.
25. Larsen O, Andersson S, da Silva Z et al. J Acquir Immune Defic Syndr 2000: 25: 157-163.
26. Andersson S, Dias F, Mendez P J et al. J Acquir Immune Defic Syndr Hum Retrovirol 1997: 15: 320-322.
27. Dumas M, Houinato D, Verdier M et al. AIDS Res Hum Retroviruses 1991: 7: 447-451.
28. BlattnerW A, Saxinger C, Riedel D et al. J Acquir Immune Defic Syndr 1990: 3: 1102-1108.
29. Murphy E L, Figueroa J P, Giggs W N et al. Am J Epidemiol 1991: 133: 1114-1124.
30. Koga Y, Iwanaga M, Soda M et al. J Med Virol 2010: 82: 668-674.
31. Morofuji-Hirata M, Kajiyama W, Nakashima K et al. Am J Epidemiol 1993: 137: 43-48.
32. Kinoshita T, Imamura J, Nagai H et al. Int J Cancer 1993: 54: 16-19.
33. de Thé G, Bomford R. AIDS Res Hum Retroviruses 1993: 9: 381-386.
34. Murphy E L, Hanchard B, Figueroa J P et al. Int J Cancer 1989: 43: 250-253.
35. Kaplan J E, Osame M, Kubota H et al. J Acquir Immune Defic Syndr 1990: 3: 1096-1101.
36. Rathsam-Pinheiro R H, Boa-Sorte N, Castro-Lima-Vargens C et al. Rev Soc Bras Med Trop 2009: 42: 633-637.
37. Pinheiro S R, Martins-Filho O A, Ribas J G et al. Am J Ophthalmol 2006: 142: 811-815.
38. Uchiyama T, Yodoi J, Sagawa K et al. Blood 1977: 50: 481-492.
39. Tokudome S, Tokunuga O, Shimamoto Y et al. Cancer Res 1989: 49: 226-228.
40. Tajima K, Kuroishi T. Jpn J Clin Oncol 1985: 15: 423-430.
41. Gessain A, Vernant J C, Maurs L et al. Lancet 1985: 326: 407-409.
42. Osame M, Usuku K, Izumo S et al. Lancet 1986: 327: 1031-1032.
43. Osame M, Matsumoto M, Usuku K et al. Ann Neurol 1987: 21: 117-122.
44. Zuninovic V, Arango C, Biojo R et al. Ann Neurol 1988: 23 (suppl): S127-S132.
45. Rodgers-Johnson P, Morgan O S C, Mora C et al. Ann Neurol 1988: 23 (suppl): S121-S126.
46. Nakada K, Kohakura M, Komoda H et al. Lancet 1984: 1: 633.
47. Nakada K, Yamaguchi K, Furugen S et al. Int J Cancer 1987: 40: 145-148.
48. Robinson R D, Lindo J F, Nova S A et al. J Infect Dis 1994: 169: 692-696.
49. Hyashi J, Kishihara Y, Yoshimura E et al. Am J Trop Med Hyg 1997: 56: 71-75.
50. Einsiedel L, Fernandes L. Intern Med J 2008: 38: 697-703.
51. Gotuzzo E, Terashima A, Alvarez H et al. Am J Trop Med Hyg 1999: 60: 146-149.
52. Brites C, Weyll M, Pedroso C et al. AIDS 2002: 16: 1292-1293.
53. Mollison L C, Lo S T, Marning G. Lancet 1993: 341: 1281-1282.
54. Goncalves D U, Guedes A C, Proietti A B et al. Am J Trop Med Hyg 2003: 68: 562-565.
55. Sweet R D. Br J Dermatol 1964: 76: 349-356.
56. Suite M, Jack N, Basdeo-Maharaj K et al. AIDS Res Hum Retroviruses 1994: 10: 447.
57. Hino S, Yamaguchi K, Katamine S et al. Jpn J Cancer Res 1985: 76: 474-480.
58. Kusuhara K, Sonada S, Takahashi K et al. Int J Cancer 1987: 40: 755-757.
59. Wiktor S Z, Pate E J, Rosenberg P S et al. J Hum Virol 1997: 1: 37-44.
60. Takahashi K, Takezaki T, Oki T et al. Int J Cancer 1991: 49: 673-677.
61. Hino S, Katamine S, Miyamoto T et al. J Clin Invest 1995: 95: 2920-2925.
62. Ureta-Vidal A, Angelin-Duclos C, Tortevoye et al. Int J Cancer 1999: 82: 832-836.
63. Oliveira Mde F, Brites C, Ferraz N et al. Clin Infect Dis 2005: 40: 90-96.
64. Bittencourt A L, Oliveira Mde F, Brites C et al. Eur J Dermatol 2005: 15: 26-30.
65. Primo J, Siqueira I, Nascimiento M C et al. Braz J Med Biol Res 2009: 42: 761-764.
66. Blank A, Herrera M, Lourido M A et al. Lancet 1995: 346: 710.
67. Mahé A, Meertens L, Ly F et al. Br J Dermatol 2004: 150: 958-965.
68. Hlela C, Mosam A, Ramdial P et al. S Afr Med J 2006: 96: 458-460.
69. Tsukasaki K, Yamada Y, Ikeda S et al. Int J Cancer 1994: 57: 293.
70. Aquije M, Ballona Chambergo R. Folia Dermatol Peruana 2002: 13: 27-31.
71. Bittencourt A L, Oliveira Mde F, Ferraz N et al. Eur J Dermatol 2006: 16: 62-66.
72. Maragno L, Casseb J, Fukumori L M et al. Int J Dermatol 2009: 48: 723-730.
73. LaGrenade L, Sonoda S, Miller W et al. Am J Med Genet 1996: 61: 37-41.
74. Mahé A, Chollet-Martin S, Gessain A. Lancet 1999: 354: 1386.
75. Farre L, Oliveira Mde F, Primo J et al. Clin Infect Dis 2008: 46: 440-442.
76. Hanchard B, LaGrenade L, Carberry C et al. Lancet 1991: 338: 1593.
77. LaGrenade L, Morgan C, Carberry C et al. West Indian Med J 1995: 44: 34-35.
78. Oliveira Mde F, Bittencourt A L, Brites C et al. J Neurol Sci 2004: 222: 35-38.
79. LaGrenade L, Venkateshan C N, Manns A et al. AIDS Res Hum Retroviruses 1994: 10 (suppl 3): S145.
80. Leung K, Nable G. Nature 1988: 333: 776-778.
81. Etoh K-I, Tamiya S, Yamaguchi K, et al. Cancer Res 1997: 57: 4862-4867.
82. Cavrois M, Leclercq I, Gout O et al. Oncogene 1998: 17: 77-82.
83. Villiger P M, Cronin M T, Amenomori T et al. J Immunol 1991: 146: 550-559.
84. Goon P K, Hanon E, Igakura T et al. Blood 2002: 99: 3335-3341.
85. Goon P K, Igakura T, Hanon E et al. J Virol 2003: 77: 9716-9722.
86. Biddison W E, Kubota R, Kawanishi T et al. J Immunol 1997: 159: 2018-2025.
87. Nascimento M C, Primo J, Bittencourt A L et al. Clin Exp Immunol 2009: 156: 455-462.
88. Blattner W A, Charurat M E. Human lymphotropic viruses: HTLV-1 and HTLV-2. In: Richman D D, Whitley R J, Hayden F G, eds. Clinical Virology, 3rd edn. Washington, DC, USA: ASM Press; 2009: 709-736.
89. Ohtsuki Y, Akagi T, Takahashi K et al. Arch Virol 1982: 73: 69-73.
90. Koyanagi Y, Itoyama Y, Nakamura N et al. Virology 1993: 196: 25-33.
91. Hanon E, Stinchcombe J C, Saito M et al. Immunity 2000: 13: 657-664.
92. Nagai M, Brennan M B, Sakai J A et al. Blood 2001: 98: 1858-1861.
93. Jones K S, Petro-Sadowski C, Huang Y K et al. Nat Med 2008: 14: 429-436.
94. Hoffman P M, Dhib-Jalbut S, Mikavits J A et al. Proc Natl Acad Sci USA 1992: 89: 11784-11788.
95. Takenouchi N, Jones K S, Lisinski I et al. J Virol 2007: 81: 1506-1510.
96. Jin Q, Alkhatib B, Cornetta K et al. Virology 2010: 396: 203-212.
97. Igakura T, Stinchcombe J, Goon P et al. Science 2003: 299: 1713-1716.
98. Pais-Correia A-M, Sachse M, Guadagnini S et al. Nat Med 2010: 16: 83-90.
99. Okochi K, Sato H, Hinuma Y. Vox Sang 1984: 46: 245-253.
100. Gaudray G, Gachon F, Basbous J et al. J Virol 2002: 76: 12813-12822.
101. Ciminale V, Pavlakis G N, Derse D et al. J Virol 1992: 66: 1737-1745.
102. Koralnik I, Gessain A, Klotman M E et al. Proc Natl Acad Sci USA 1992: 89: 8813-8817.
103. Koralnik I J, Fullen J, Franchini G. J Virol 1993: 67: 2360-2366.
104. Ding W, Albrecht B, Luo R et al. J Virol 2001: 75: 7672-7682.
105. Johnson J M, Nicot C, Fullen J et al. J Virol 2001: 75: 6086-6094.
106. Zhang W, Nisbet J W, Bartoe J T et al. J Virol 2000: 74: 11270-11277.
107. Ciminale V, Zotti L, D'Agostino D M et al. Oncogene 1999: 18: 4505-4514.
108. Berneman Z N, Gartenhaus R B, Reitz M S et al. Proc Natl Acad Sci USA 1992: 89: 3005-3009.
109. Felber B K, Paskalis H, Kleinman-Ewing C et al. Science 1985: 222: 675-679.
110. Liang M-H, Geisbert T, Yao Y et al. J Virol 2002: 76: 4022-4033.
111. Caralho E M, Bacellar O, Porto A F et al. J Acquir Immune Defic Syndr 2001: 27: 1-6.
112. Elovaara I, Koenig S, Brewah A Y et al. J Exp Med 1993: 177: 1567-1573.
113. Jacobson S, McFarlin D E, Robinson S et al. Ann Neurol 1992: 32: 651-657.
114. Metkar S S, Wang B, Aguilar-Santelises M et al. Immunity 2002: 26: 417-428.
115. Bittencourt A L, Barbosa H S, Vieira M D et al. Acta Oncol 2009: 48: 598-604.
116. Lee R, Schwartz R. J Am Acad Dermatol 2011: 64: 152-160.
117. Cruickshank J K, Rudge P, Dalgleish A G et al. Brain 1989: 112: 1057-1090.
118. Shimoyama M, Takatsuki K, Araki K et al. Br J Haematol 1991: 79: 428-437.
119. Mulloy J C, Kislyakova T, Cereseto A et al. J Virol 1998: 72: 8852-8860.
120. Pise-Masison C A, Mahieux R, Jiang H et al. Mol Cell Biol 2000: 20: 3377-3386.
121. Kao S-Y, Marriott S J. J Virol 1999: 73: 4299- 4304.
122. Jin D-Y, Spencer F, Jeang K-T. Cell 1998: 93: 81-91.
123. Kashiwagi K, Furusyo N, Nakashima H et al. Am J Trop Med Hyg 2004: 70: 158-163.
124. Sawada Y, Hino R, Hama K et al. Blood, 2011: 117: 3961-3967.
125. Suite M, Jack N, Basdeo-Maharaj K et al. J Acquir Immune Defic Syndr 1999: 20: A68.
126. Biggar R J, Ng J, Kim N et al. J Infect Dis 2006: 193: 277-282.
127. Usuku K, Sonoda S, Osame M et al. Ann Neurol 1988: 23 (suppl): S143-S150.
128. Ishida T, Hinuma Y. Nature 1986: 322: 504.
129. Sonoda S, Li H C, Tajima K. Cancer Sci 2011: 102: 295-301.
130. Berkowitz F E. Ann Trop Paediatr 1983: 3: 79-83.
131. Isaack H, Mbise R L, Hirji K F. East Afr Med J 1992: 69: 433-436.
132. Friedland I R. Ann Trop Paediatr 1992: 12: 433-440.
133. Cederholm T, Jä gren C, Hellström K. Am J Med 1995: 98: 67-74.
134. Yasunaga J-I, Sakai T, Nosaka K et al. Blood 2001: 97: 3177-3183.
135. Shimauchi T, Kabashima K, Nakashima D et al. Int J Cancer 2007: 121: 2585-2590.
136. Simpson A B, Yousef E, Hossain J. Allergy Asthma Proc 2010: 31: 232-237.
137. Hlela C, Marafioti T, Bangham C et al. Br J Dermatol 2010; 162 (BSID Abstract): 934.
138. Shevach E M. Regulatory/Suppressor T cells. In: Paul W E, ed. Fundamental Immunology, 6th edn. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, 2008: 943-982.
139. Fontenot J D, Gavin M A, Rudensky A Y et al. Nat Immunol 2003: 4: 330-336.
140. Itoh M, Takahashi T, Sakaguchi N et al. J Immunol 1999: 162: 5317-5326.
141. Asano M, Toda M, Sakaguchi N et al. J Exp Med 1996: 184: 387-396.
142. Sakaguchi S, Sakaguchi N, Asano M et al. J Immunol 1995: 155: 1151-1164.
143. Bennett C L, Christie J, Ramsdell F et al. Nat Genet 2001: 27: 20-21.
144. Liyanage U K, Moore T T, Joo H G et al. J Immunol 2002: 169: 2756-2761.
145. Turk M J, Guevara-Patiño J A, Rizzuto G A et al. J Exp Med 2004: 200: 771-782.
146. Yu P, Lee Y, Liu W et al. J Exp Med 2005: 201: 779-791.
147. Smith F J, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 337-342.
148. Akiyama M, Shimizu H. Exp Dermatol 2008: 17: 373-382.
149. Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 441-446.
150. Weidinger S, IIIig T, Baurecht H et al. J Allergy Clin Immunol 2006: 118: 214-219.
151. van den Oord R A, Sheikh A. BMJ 2009: 339: b2433.
152. Angelova-Fischer I, Mannheimer A-C, Hinder A et al. Exp Dermatol 2011: 20: 351-356.
153. Bos J D, Brenninkmeijer E E, Schram M E et al. Exp Dermatol 2010: 19: 325-331.
154. Proksch E, Brandner J M, Jensen J-M. Exp Dermatol 2008: 17: 1063-1072.
155. Lee K H, Cho K-A, Kim J-Y et al. Exp Dermatol 2011: 20: 149-151.
156. Kezic S, Kemperman P M, Koster E S et al. J Invest Dermatol 2008: 128: 2117-2119.
157. Nemoto-Hasebe I, Akiyama M, Nomura T et al. J Invest Dermatol 2009: 129: 682-689.
158. Vestergaard C, Hvid M, Johansen C et al. Chem Immunol Allergy 2012: 96: 77-80.
159. Amir M, Paul J, Batchelor B et al. Eur J Clin Microbiol Infect Dis 1995: 14: 34-40.
160. Battan R, Raviglione M C, Wallace J et al. Am J Infect Control 1991: 19: 98-100.
161. Ganesh R, Castle D, McGibbon D et al. Lancet 1998: 2: 558.
162. Raviglione M C, Marluz P, Pablos-Mendez A et al. Am J Infect Control 1990: 18: 64-69.
163. Weinke T, Schiller R, Fehrenbach F J et al. Eur J Clin Microbiol Infect Dis 1992: 11: 985-989.
164. Aly R, Shinefield H R, Maibach H I. Staphylococcus aureus adherence to nasal epithelial cells: studies of some parameters. In: Maibach H I, Aly R, eds. Skin Microbiology. New York: Springer-Verlag, 1981: 171-179.
165. Williams R E. Bacterial Rev 1963: 27: 56-71.
166. Kluytmans J, van Belkum A, Verbrugh H. Clin Microbiol Rev 1997: 10: 505-520.
167. Reagan D R, Doebbeling B N, Pfaller M A et al. Ann Intern Med 1991: 114: 101-106.
168. Hudson I R. J Hosp Infect 1994: 27: 81-98.
169. Wertheim H F, Melles D C, Vos M C et al. Lancet Infect Dis 2005: 5: 751-762.
170. Kaplan D H, Jenison M C, Saeland S et al. Immunity 2005: 23: 611-620.
171. Shimauchi T, Imai S, Hino R et al. Clin Cancer Res 2005: 11: 2427-2435.